We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

Baxter International Inc. has announced that it has entered into a definitive agreement to sell its proprietary Vero cell technology and related assets, including its production facility in Bohumil, Czech Republic, to Nanotherapeutics, Inc. Financial details were not disclosed.

The Vero cell platform is an advanced, cell-based technology for vaccines production. The agreement with Nanotherapeutics includes all assets related to the platform, including vaccines for H5N1, H1N1 and seasonal influenza. The agreement also includes investigational vaccine programs for Ross River virus, Chikungunya disease and West Nile virus.

In recent weeks, the company has also completed the sale of its commercial vaccines business and related manufacturing facilities to Pfizer Inc.

"The divestiture of the vaccines franchise will allow Baxter BioScience to enhance focus in core therapeutic areas of hematology, oncology and immunology, as it prepares to become an independent biopharmaceutical company," said Ludwig Hantson, Ph.D., president of Baxter BioScience. "In addition, these transactions provide flexibility to direct resources toward strategic priorities that will drive future growth."

Baxter's financial results for 2014 reflect the operating results from its vaccines franchise as discontinued operations.

Advertisement